Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco M Muggia

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|May 7, 2009
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference CenterFranco M Muggia, Godefridus J Peters, Joseph R Landolph
Oncology (Williston Park, N.Y.)|April 5, 2011
Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when?Maria José Echarri Gonzalez, Robin Green, Franco M Muggia
Seminars in Oncology|February 19, 2005
Liposomal anthracycline treatment for ovarian cancerMaurie Markman, Alan N Gordon, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Joel Sorosky, et al.
Gynecologic Oncology|August 7, 2004
Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupFranco M Muggia, John A Blessing, Ramon McGehee, et al.
Ecancermedicalscience|June 29, 2016
Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?Alexandra Silverton, Roy A Raad, Leah Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's DiscoveryFranco M Muggia, Andrea Bonetti, James D Hoeschele, et al.
Ecancermedicalscience|January 30, 2016
Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndromeMelissa K Frey, Gizelka David-West, Khushbakhat R Mittal, et al.
Gynecologic Oncology|April 2, 2002
Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case reportBrian J Hines, Robert F Porges, Kush Mittal, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2018
Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancerJessica Lee, John P Curtin, Franco M Muggia, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|May 7, 2009
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference CenterFranco M Muggia, Godefridus J Peters, Joseph R Landolph
Oncology (Williston Park, N.Y.)|April 5, 2011
Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when?Maria José Echarri Gonzalez, Robin Green, Franco M Muggia
Seminars in Oncology|February 19, 2005
Liposomal anthracycline treatment for ovarian cancerMaurie Markman, Alan N Gordon, William P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Joel Sorosky, et al.
Gynecologic Oncology|August 7, 2004
Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupFranco M Muggia, John A Blessing, Ramon McGehee, et al.
Ecancermedicalscience|June 29, 2016
Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?Alexandra Silverton, Roy A Raad, Leah Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's DiscoveryFranco M Muggia, Andrea Bonetti, James D Hoeschele, et al.
Ecancermedicalscience|January 30, 2016
Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndromeMelissa K Frey, Gizelka David-West, Khushbakhat R Mittal, et al.
Gynecologic Oncology|April 2, 2002
Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case reportBrian J Hines, Robert F Porges, Kush Mittal, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2018
Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancerJessica Lee, John P Curtin, Franco M Muggia, et al.
Pageof 6